Evidence map›Paper›PMID 29599068›Full record

Trial reportThe Journal of pediatrics2018

Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.

Carol J Blaisdell, James Troendle, Anne Zajicek, Prematurity and Respiratory Outcomes Program

Registry-linked trialAbstract readClinical TrialMulticenter StudyObservational Study
In one paragraph

Trial report in The Journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01435187 (Prematurity and Respiratory Outcomes Program), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01435187 completednot on this map

Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol

TypeobservationalSponsorUniversity of PennsylvaniaRan2011 to 2016Enrolled835ConditionsPrematurity, Respiratory Disease
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. World Prematurity Day: it takes an NIH village to prevent preterm birth and improve treatments for preterm infants.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  6. Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
  7. Use of diuretics in the neonatal period.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  8. An Update on the Prevention and Management of Bronchopulmonary Dysplasia.Pediatric health, medicine and therapeutics · 2021
    Review
  9. Bronchopulmonary Dysplasia: Then, Now, and Next.Pediatric allergy, immunology, and pulmonology · 2020
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Carol J BlaisdellDivision of Lung Diseases, National, Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Electronic address: carol.blaisdell@nih.gov.
James TroendleOffice of Biostatistics Research, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
Anne ZajicekObstetric and Pediatric Pharmacology and Therapeutics Branch, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.
Prematurity and Respiratory Outcomes Program
National Heart Lung and Blood Institute · USEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

Data Coordinating Center for the Prematurity and Respiratory Outcomes ProgramU01HL101794 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SCHMIDT, BARBARA · 2010 to 2014
$10.3M
Gastrin-Releasing Peptide and Bronchopulmonary DysplasiaR01HL105702 · NHLBI · DUKE UNIVERSITY · PI COTTEN, CHARLES MICHAEL, DAVIS, STEPHANIE DUGGINS · 2011 to 2015
$2.8M
Biomarkers of Immunologic Function and Preterm Respiratory OutcomesU01HL101800 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CHOUGNET, CLAIRE A., JOBE, ALAN H · 2010 to 2014
$2.5M
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic PreemiesU01HL101813 · NHLBI · UNIVERSITY OF ROCHESTER · PI MARIANI, THOMAS J, PRYHUBER, GLORIA S · 2010 to 2014
$2.4M
Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)U01HL101456 · NHLBI · VANDERBILT UNIVERSITY · PI ASCHNER, JUDY LYNN · 2010 to 2014
$2.4M
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes ProgramU01HL101798 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALLARD, PHILIP L., KELLER, ROBERTA L · 2010 to 2014
$2.1M
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary DysplasiaU01HL101465 · NHLBI · WASHINGTON UNIVERSITY · PI FERKOL, THOMAS W, WARNER, BARBARA B · 2010 to 2014
$2.1M
CD8 T Cell Dysregulation in Premature InfantsK08AI108870 · NIAID · UNIVERSITY OF ROCHESTER · PI SCHEIBLE, KRISTIN · 2014 to 2016
$539k
Intramural NIH HHS Z99 OD999999NHLBI NIH HHS R01 HL105702NHLBI NIH HHS U01 HL101456NHLBI NIH HHS U01 HL101465NHLBI NIH HHS U01 HL101794NHLBI NIH HHS U01 HL101798NHLBI NIH HHS U01 HL101800NHLBI NIH HHS U01 HL101813NIAID NIH HHS K08 AI108870
6 · The paper itself

Abstract

objectiveTo determine if daily respiratory status improved more in extremely low gestational age (GA) premature infants after diuretic exposure compared with those not exposed in modern neonatal intensive care units. STUDY

designThe Prematurity and Respiratory Outcomes Program (PROP) was a multicenter observational cohort study of 835 extremely premature infants, GAs of 23

resultsInfants in the diuretic exposed group of PROP were of lower mean GA and lower mean birth weight (P < .0001). Compared with infants unexposed to diuretics, the probability (adjusted for infant characteristics including GA, birth weight, sex, and respiratory status before receiving diuretics) that the exposed infants were on a higher level of respiratory support was significantly greater (OR, >1) for each day after the initial day of diuretic exposure.

conclusionsOur analysis did not support the ability of diuretics to substantially improve the extremely premature infant's respiratory status. Further study of both safety and efficacy of diuretics in this setting are warranted.

trial registrationClinicaltrials.gov: NCT01435187.

Indexed as

Airway ManagementCohort StudiesDiureticsFemaleGestational AgeHumansInfant, Extremely PrematureInfant, NewbornIntensive Care Units, NeonatalMaleRespirationRespiratory Distress Syndrome, NewbornUnited StatesDiureticsdiureticprematurityrespiratory distress

Identifiers

PMID29599068
PMCPMC5970973
OpenAlexW2791798686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.